Nath Bio-Genes (I) Ltd
NSE:NATHBIOGEN
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
EV/EBIT
Enterprise Value to EBIT (EV/EBIT) ratio compares a company`s total enterprise value to its earnings before interest and taxes. It shows how much investors are paying for each dollar of the company`s earnings, including both equity and debt.
Enterprise Value to EBIT (EV/EBIT) ratio compares a company`s total enterprise value to its earnings before interest and taxes. It shows how much investors are paying for each dollar of the company`s earnings, including both equity and debt.
Valuation Scenarios
If EV/EBIT returns to its 3-Year Average (4.7), the stock would be worth ₹194.97 (14% upside from current price).
| Scenario | EV/EBIT Value | Implied Price | Upside/Downside |
|---|---|---|---|
| Current Multiple | 4.1 | ₹171.66 |
0%
|
| 3-Year Average | 4.7 | ₹194.97 |
+14%
|
| 5-Year Average | 7.9 | ₹328.97 |
+92%
|
| Industry Average | 24.2 | ₹1 009.92 |
+488%
|
| Country Average | 23.3 | ₹970.02 |
+465%
|
Forward EV/EBIT
Today’s price vs future ebit
Peer Comparison
| Market Cap | EV/EBIT | P/E | ||||
|---|---|---|---|---|---|---|
| IN |
|
Nath Bio-Genes (I) Ltd
NSE:NATHBIOGEN
|
3.3B INR | 4.1 | 7.6 | |
| US |
A
|
Archer-Daniels-Midland Co
XETRA:ADM
|
28.3B EUR | 27.6 | 30.7 | |
| US |
|
Bunge Ltd
NYSE:BG
|
24.2B USD | 22 | 29.6 | |
| SG |
|
Wilmar International Ltd
SGX:F34
|
24.4B SGD | 7.8 | 13.3 | |
| CN |
|
Tongwei Co Ltd
SSE:600438
|
82.5B CNY | -16.7 | -9.9 | |
| MY |
S
|
Sime Darby Plantation Bhd
KLSE:SIMEPLT
|
41.3B MYR | 23.7 | 22.2 | |
| US |
|
Darling Ingredients Inc
NYSE:DAR
|
9.5B USD | 32.1 | 151.6 | |
| US |
|
Ingredion Inc
NYSE:INGR
|
7.1B USD | 7.6 | 9.8 | |
| MY |
|
IOI Corporation Bhd
KLSE:IOICORP
|
26.6B MYR | 18.8 | 16.6 | |
| MY |
K
|
Kuala Lumpur Kepong Bhd
KLSE:KLK
|
23.1B MYR | 13.8 | 23.6 | |
| CN |
|
New Hope Liuhe Co Ltd
SZSE:000876
|
39.1B CNY | 27.5 | 39.3 |
Market Distribution
| Min | 0.4 |
| 30th Percentile | 15.7 |
| Median | 23.3 |
| 70th Percentile | 34.7 |
| Max | 48 145.1 |
Other Multiples
Nath Bio-Genes (I) Ltd
Glance View
Nath Bio-Genes (India) Ltd. engages in the production and marketing of seeds. The company is headquartered in Mumbai, Maharashtra and currently employs 462 full-time employees. The company went IPO on 2014-01-28. The firm is dealing in the Seed Cultivation segment. The Company’s products categories include oilseeds and fiber, field crops, vegetables and plant nutrition. The Company’s products include field crops, cereals, fiber and oilseeds, vegetable crops and micronutrient supplements. Its cereals range includes maize, paddy, pearl millet and wheat. The company offers fiber and oils seeds, such as cotton, mustard and sunflower. Its nutritional supplements include Win-Chi-Win and Bio-Energy. The firm's vegetable crop range includes chili, okra, tomato, bottle gourd, bitter gourd, cucumber and coriander. The firm has seed processing facilities processing plants located in Maharashtra and Andhra Pradesh. The firm also has processing arrangements in Gujarat, Karnataka, Tamil Nadu, Madhya Pradesh and Rajasthan on custom basis.
